Articles


Repros Therapeutics Receives Investigational Review Board Approval To Commence Low Dose For Proellex® Study At ICON Site

July 22, 2010

You can view this news at http://www.businesswire.com/news/home/20100722005184/en.

 

 

 

Most Popular

Need Information?

Please wait... busy